Under the agreed terms, Beazley shareholders will receive total value of 1,335 pence per share, consisting of 1,310 pence in cash plus a permitted dividend of 25 pence. The aggregate cash consideration is approximately $10.9 billion and will be funded through a mix of existing cash (~$3.0bn), new debt facilities (~$2.9bn), and a capital raise and share placement via accelerated bookbuild (~$5.0bn).
The combination brings together two highly complementary specialty platforms. On a pro forma basis, the merged business would represent roughly $15 billion in specialty gross written premiums as of December 31, 2024, building on Zurich’s own specialty franchise, which generated about $9 billion in specialty GWP in 2025.
Zurich expects the transaction to generate approximately $150 million in annual pre-tax run-rate cost savings by 2029, alongside meaningful capital synergies, including an estimated $1 billion of one-off capital extraction within two years of completion. The insurer also anticipates incremental revenue opportunities exceeding $1 billion annually in the medium term.
Financially, Zurich projects mid-single-digit core EPS accretion from year one after completion and a double-digit return on investment over time. The deal is also expected to support its 2025-2027 targets of more than 9% core EPS CAGR, core RoE above 23%, and cumulative cash remittances exceeding $19 billion, while maintaining its dividend policy. Post-transaction, Zurich estimates its SST ratio will decline by about 30 percentage points and its Moody’s leverage ratio will rise by roughly three points, leaving the group with what it describes as a strong pro forma capital position.
The acquisition will be implemented through a court-sanctioned scheme of arrangement, subject to shareholder, regulatory, and antitrust approvals, with completion anticipated in the second half of 2026.
At roughly $10.9 billion, the proposed acquisition ranks among the larger insurance-sector deals of the past decade, though it sits below the very largest industry mega-mergers:
Against that backdrop, Zurich’s move for Beazley stands out as one of the largest specialty-focused acquisitions in recent years rather than an industry-wide consolidation mega-deal. Its strategic emphasis is narrower but targeted: deepening underwriting capabilities and scale in specialty lines rather than transforming the entire insurance landscape.